The Biological Role of PI3K Pathway in Lung Cancer
Lung cancer is the primary cause of cancer-related mortality worldwide and although improvements in treatment have been achieved over the last few years, long-term survival rates for lung cancer patients remain poor. Therefore, there is an imperative need for molecularly targeted agents that will ac...
Main Authors: | Kostas N. Syrigos, Muhammad W. Saif, Evangelos G. Sarris |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2012-11-01
|
Series: | Pharmaceuticals |
Subjects: | |
Online Access: | http://www.mdpi.com/1424-8247/5/11/1236 |
Similar Items
-
Mechanisms of Resistance to PI3K Inhibitors in Cancer: Adaptive Responses, Drug Tolerance and Cellular Plasticity
by: Sarah Christine Elisabeth Wright, et al.
Published: (2021-03-01) -
Effect of PI3K/AKT Pathway on Cisplatin Resistance in Non-small Cell Lung Cancer
by: Yu ZHANG, et al.
Published: (2014-08-01) -
Targeting the PI3K/Akt/mTOR pathway in non‐small cell lung cancer (NSCLC)
by: Aaron C. Tan
Published: (2020-03-01) -
PI3K Signalling in B cell and T cell Biology
by: Klaus eOkkenhaug, et al.
Published: (2014-11-01) -
Genomic determinants of PI3K pathway inhibitor response in cancer
by: Julian eDownward, et al.
Published: (2012-08-01)